Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Hira Bahadur Ale et al.|Nature Communications|2021Cited by 49
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Hira Bahadur Ale et al.|Nature Communications|2021Cited by 1
Changes in driving distance to specialist physicians in the era of virtual care: a population-based cohort study in Ontario, CanadaAndrea Evans, Natasha Saunders, Eyal Cohen et al.|Canadian Medical Association Journal|2025Cited by 1
Effectiveness of Enhanced Developmental Screening at 18 Months to Identify Developmental DelaysEmily Hamovitch, Natasha Saunders, Eyal Cohen et al.|Journal of Developmental & Behavioral Pediatrics|2025Cited by 0